Athyrium Capital Management, LP

Athyrium is a specialized asset management company formed in 2008 to focus on investment opportunities in the broader healthcare and life sciences sectors encompassing biotechnology, pharmaceuticals, healthcare services, healthcare technology and medical devices and products. Our Focus The Athyrium team has substantial investment experience in the healthcare sector across a wide range of asset classes, including public equity, private equity, fixed income, royalties and other structured securities. Athyrium advises funds with over $4.6 billion of committed capital. We value our investors and are thankful for the trust they have placed in us. ▪ Up to $200 million per investment with ability to flex up opportunistically ▪ Public and private companies ▪ Commercial-stage companies with compelling products and differentiated services ▪ Industry-leading management teams ▪ Multi-year commitments with opportunity to upsize over time ▪ Global investment mandate